Actos Maker Destroyed Evidence to Block Victims' Lawsuits, Jury Finds

Thursday, December 4, 2014

So far, around 8,000 patients in the United States have filed lawsuits against Japanese pharmaceutical giant Taketa alleging their blockbuster diabetes drug Actos caused them to develop bladder cancer.

Bloomberg reports eight of these cases have reached trial already, with five resulting in verdicts for the victims. In April, a jury awarded an astonishing $9 billion to a New York man afflicted with bladder cancer after Actos use.

A judge has since reduced that award to around $37 million, but another recent award of $2 million for a Philadelphia woman demonstrates juries aren’t afraid to hold the company accountable.

Now, reports indicate Taketa might have destroyed evidence to try to keep plaintiffs in future cases from having similar success. A jury last month found that the company eliminated records detailing how they developed and marketed Actos, and that doing so blocked patients’ chances of maintaining claims.

The jury awarded a former baker in West Virginia who developed bladder cancer $155,000 in compensation after Taketa’s fraud, but this is only a fraction of what his claim may have been worth had he been able to get the destroyed evidence.

Next up, more than 3,500 cases are pending in a special Actos federal court in Louisiana. Taketa will have to decide whether to keep incurring public embarrassment, or reach a settlement with victims.

DrugNews will continue to provide updates on Actos lawsuits and warnings, and can connect anyone affected to a qualified lawyer for quick help.


Feeley, J. Taketa Ordered to Pay $155,000 for Destroying Actos Files. Bloomberg News. (November 17, 2014). Retrieved from


diabetes drug

Other drugs and devices in the news:

Tuesday, April 14, 2020
Sudden Rise in Elmiron Eye Disease Cases Raises Questions

Elmiron is a mild blood-thinner drug that has been around since 1996 and is prescribed to treat bladder pain or inflammation, a condition called interstitial cystitis.

Monday, April 13, 2020
Asbestos Mesothelioma
Estimated $30 Billion Left Unclaimed in Asbestos Victim Funds

Since many of the companies that sold asbestos or used it in their products have long since gone out of business, people who are diagnosed with asbestos-related cancers often think it’s too late to file a lawsuit.

Get in touch with us.

Call, email or live chat with us today to see how we can help.

Need a quick answer? Call us!
Reach out to us by email.
live chat with DrugNews
We are here to help now